{
    "nctId": "NCT01249456",
    "briefTitle": "Safety and Efficacy Study of Femara(Letrozole) as an Extended Adjuvant Treatment in Breast Cancer Patients",
    "officialTitle": "An Observational, Multicenter Study on the Safety and Efficacy of Femara(Letrozole) as an Extended Adjuvant Treatment in Breast Cancer Patients Who Completed Adjuvant Tamoxifen or Toremifen Treatment",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Letrozole",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 392,
    "primaryOutcomeMeasure": "To identify unknown adverse reactions, especially serious adverse reactions",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Written informed consent form\n* Postmenopausal patients who had had a histologically or cytologically confirmed breast cancer removed at the time of diagnosis with no evidence of metastases and who had completed over 5 years of adjuvant therapy with tamoxifen or toremifen before entering the study\n* Age \u226550 years with cessation of menses and Age \\<50 years Postmenopausal status defined by one of the following:\n\n  * FSH level \\> 30-40 IU/L\n  * cessation of menses over the past 1 year\n  * are/become amenorrheic due to either chemotherapy or LHRH, are/become amenorrheic due to surgical ovarian ablation\n* The tumor was to be ER and/or PgR-positive or the receptor status could have been unknown\n* No evidence of recurrence of the disease at entry\n* Patient must be accessible for follow-up\n\nExclusion Criteria:\n\n* Those patients known to have had receptor-negative primary tumors\n* Any concurrent malignancy\n* Patients who previously received hormone replacement therapy (HRT) during 5 years of adjuvant therapy with tamoxifen or toremifen\n* Patients who are currently receiving other aromatase inhibitors, or chemotherapy\n* Patients who have serious cardiovascular or hepatic disease with significantly abnormal daily function and/or laboratory results\n* Life expectancy \\< 12 months",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}